Educational paper: therapy of infantile haemangioma--history and current state (part II)

Sherief Janmohamed, Gerard Madern, pc de laat, A.p. Oranje

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


Infantile haemangioma (IH) is the most frequent tumour of infancy. Although it is benign and self-limiting, severe complications can arise due to localisation and fast tumour growth. Also, IHs leave scars after regression in more than half of the cases. Management and therapy of IH have changed greatly after 2008. This update provides an overview of the older therapy options before 2008, which mainly consisted of the administration of corticosteroids, and discusses the modern management with new therapy options such as beta-blockers (both systemically and topically).

Conclusion: beta-blockers are promising and are currently preferred above corticosteroids, but beta-blockers still do not give a definitive treatment.
Original languageEnglish
Pages (from-to)259-266
JournalEur J Pediatr
Issue number2
Publication statusPublished - Feb 2015


  • infantile haemangioma
  • propranolol
  • therapy
  • timolol
  • scoring system
  • beta-blockers
  • corticosteroids


Dive into the research topics of 'Educational paper: therapy of infantile haemangioma--history and current state (part II)'. Together they form a unique fingerprint.

Cite this